MicroRNA-200c contributes to injury from transient focal cerebral ischemia by targeting Reelin

Creed M Stary1, Lijun Xu1, Xiaoyun Sun1

  • 1From the Department of Anesthesia, Stanford University School of Medicine, CA (C.M.S, L.X., X.S., Y.-B.O., J. Leong, J. Li, X.X., R.G.G.); and Department of Biology, Westfield State University, MA (R.E.W.).

Stroke
|January 22, 2015
PubMed
Abstract

Insights

MicroRNA-200c inhibition reduces brain damage after stroke by increasing reelin expression. This finding suggests targeting microRNA-200c may protect against stroke-induced brain injury.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • MicroRNA (miR)-200c levels rise in the brain post-ischemia.
  • The role of miR-200c in stroke-related brain injury is not fully understood.
  • Reelin, a key protein in neuronal development, is a predicted target of miR-200c.

Purpose of the Study:

  • To investigate the role of miR-200c in transient cerebral ischemia.
  • To determine if miR-200c contributes to stroke-induced brain injury by targeting reelin.

Main Methods:

  • Mice underwent middle cerebral artery occlusion (MCAO) with miR-200c antagomir, mimic, or control infusion.
  • Infarct volume, neurological scores, and molecular levels (miR-200c, reelin mRNA/protein) were measured.
  • In vitro assays (dual luciferase, immunoblot) confirmed direct targeting of reelin by miR-200c.

Main Results:

  • miR-200c antagomir treatment reduced infarct volume and neurological deficits post-MCAO.
  • miR-200c levels inversely correlated with reelin protein expression.
  • Inhibition of miR-200c enhanced cell survival during oxidative injury, an effect dependent on reelin.

Conclusions:

  • Poststroke miR-200c increase contributes to brain cell death by suppressing reelin.
  • Reducing miR-200c levels presents a potential therapeutic strategy for mitigating stroke-induced brain injury.